Levonorgestrel Intrauterine System Versus Oral Contraceptives for Heavy Menses

Trial Profile

Levonorgestrel Intrauterine System Versus Oral Contraceptives for Heavy Menses

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2016

At a glance

  • Drugs Levonorgestrel (Primary) ; Combined oral contraceptives
  • Indications Menorrhagia
  • Focus Therapeutic Use
  • Acronyms SHiPP
  • Most Recent Events

    • 04 Oct 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.
    • 25 Nov 2015 Planned number of patients changed from 212 to 59 as reported by ClinicalTrials.gov record.
    • 10 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top